Literature DB >> 19194315

Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy.

Joseph A Politch1, Kenneth H Mayer, Deborah J Anderson.   

Abstract

BACKGROUND: Information concerning the effects of HIV-1 infection, disease progression, and antiretroviral therapy (ART) on male genital white blood cell (WBC) profiles could provide important insight into genital immune defense in HIV-infected men and seminal HIV transmission mechanisms.
OBJECTIVE: To compare concentrations of WBC populations in semen from HIV-1-seronegative (HIV) and HIV-1-seropositive (HIV) men and determine whether HIV disease stage and ART are associated with alterations in seminal WBC profiles. SUBJECTS AND METHODS: Subjects were 102 HIV men, 98 ART-naive (ART) HIV men, and 22 HIV men on dual nucleoside ART, before and 6 months after addition of indinavir. Seminal WBCs, macrophages (MØ), and T-lymphocyte subpopulations were enumerated by immunohistology technique.
RESULTS: Seminal CD4 and CD8 T-cell populations were severely depleted in most ART HIV men regardless of peripheral blood CD4 cell count. Seminal MØ counts were reduced by 50%. HIV men on dual nucleoside ART had significantly higher seminal MØ, CD4, and CD8 T-cell counts than ART HIV men; addition of indinavir led to a dramatic (>25-fold, P < 0.001) increase in seminal CD4 T-cell counts which paralleled an increase in blood CD4 cell counts. Two outlier ART HIV men with notably elevated seminal WBC profiles (>20 x 10 WBCs/mL) and infectious cell-associated HIV in semen are described.
CONCLUSIONS: HIV infection severely depletes CD4 T cells in the male genital tract as it does at other mucosal sites. This provides evidence that ART HIV men have depressed T cell-dependent genital immune defense functions and are vulnerable to other genital infections that could promote HIV transmission. Seminal CD4 T-cell counts rebounded after treatment with a viral-suppressing ART regimen, indicating that ART may reverse HIV-associated genital immunosuppression. The relative abundance of seminal MØ in HIV men suggests that these cells may be predominant HIV host cells in the male genital tract and vectors of HIV transmission. A subgroup of HIV men with exceptionally elevated seminal MØ and CD4 T-cell counts and HIV titers may be highly infectious and contribute disproportionately to HIV transmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194315      PMCID: PMC2680744          DOI: 10.1097/QAI.0b013e3181989870

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  46 in total

1.  Dynamics of seminal plasma HIV-1 decline after antiretroviral treatment.

Authors:  S Taylor; N M Ferguson; P A Cane; R M Anderson; D Pillay
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

2.  Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract.

Authors:  K B Collins; B K Patterson; G J Naus; D V Landers; P Gupta
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

3.  Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012).

Authors:  Marianne Leruez-Ville; Emmanuel Dulioust; Dominique Costabliola; Dominique Salmon; Anne Tachet; Laurent Finkielsztejn; Marta De Almeida; Benjamin Silbermann; Didier Sicard; Pierre Jouannet; Christine Rouzioux
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

4.  Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.

Authors:  Kristen V Khanna; Kevin J Whaley; Larry Zeitlin; Thomas R Moench; Karim Mehrazar; Richard A Cone; Zhaohao Liao; James E K Hildreth; Timothy E Hoen; Leonard Shultz; Richard B Markham
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis.

Authors:  S Tariq Sadiq; Stephen Taylor; Steve Kaye; Julie Bennett; Ruth Johnstone; Patrick Byrne; Andrew J Copas; Susan M Drake; Deenan Pillay; Ian Weller
Journal:  AIDS       Date:  2002-01-25       Impact factor: 4.177

6.  The evolution of the Fenway Community Health model.

Authors:  K Mayer; J Appelbaum; T Rogers; W Lo; J Bradford; S Boswell
Journal:  Am J Public Health       Date:  2001-06       Impact factor: 9.308

Review 7.  Women and HIV. Epidemiology and global overview.

Authors:  M G Fowler; S L Melnick; B J Mathieson
Journal:  Obstet Gynecol Clin North Am       Date:  1997-12       Impact factor: 2.844

8.  T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen.

Authors:  A J Quayle; C Xu; K H Mayer; D J Anderson
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

9.  Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men.

Authors:  S Taylor; H Reynolds; C A Sabin; S M Drake; D J White; D J Back; D Pillay
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

10.  Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.

Authors:  Caroline Solas; Alain Lafeuillade; Philippe Halfon; Stéphane Chadapaud; Gilles Hittinger; Bruno Lacarelle
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

View more
  18 in total

1.  MIV-150/zinc acetate gel inhibits cell-associated simian-human immunodeficiency virus reverse transcriptase infection in a macaque vaginal explant model.

Authors:  Patrick Barnable; Giulia Calenda; Thierry Bonnaire; Radhika Menon; Keith Levendosky; Agegnehu Gettie; James Blanchard; Michael L Cooney; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

Review 2.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

3.  Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1.

Authors:  Joseph A Fraietta; Yvonne M Mueller; Duc H Do; Veronica M Holmes; Mary K Howett; Mark G Lewis; Alina C Boesteanu; Sefik S Alkan; Peter D Katsikis
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

4.  Revising the Role of Myeloid cells in HIV Pathogenesis.

Authors:  Anupriya Aggarwal; Samantha McAllery; Stuart G Turville
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

5.  Persistence of genital tract T cell responses in HIV-infected women on highly active antiretroviral therapy.

Authors:  Nonhlanhla N Mkhize; Pamela P Gumbi; Lenine J Liebenberg; Yuan Ren; Peter Smith; Lynette Denny; Jo-Ann S Passmore
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

6.  Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in women.

Authors:  Kerri J Penrose; Barbra A Richardson; Guillaume Besson; Charlene S Dezzutti; Betsy C Herold; Salim S Abdool Karim; John W Mellors; Urvi M Parikh
Journal:  Sex Transm Dis       Date:  2014-11       Impact factor: 2.830

Review 7.  Interactions of HIV, other sexually transmitted diseases, and genital tract inflammation facilitating local pathogen transmission and acquisition.

Authors:  Kenneth H Mayer; Kartik K Venkatesh
Journal:  Am J Reprod Immunol       Date:  2011-01-09       Impact factor: 3.886

8.  R5 Macrophage-Tropic HIV-1 in the Male Genital Tract.

Authors:  Maria M Bednar; Blake M Hauser; Li-Hua Ping; Elena Dukhovlinova; Shuntai Zhou; Kathryn T Arrildt; Irving F Hoffman; Joseph J Eron; Myron S Cohen; Ronald Swanstrom
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

9.  Efficiency of cell-free and cell-associated virus in mucosal transmission of human immunodeficiency virus type 1 and simian immunodeficiency virus.

Authors:  Dror Kolodkin-Gal; Sandrine L Hulot; Birgit Korioth-Schmitz; Randi B Gombos; Yi Zheng; Joshua Owuor; Michelle A Lifton; Christian Ayeni; Robert M Najarian; Wendy W Yeh; Mohammed Asmal; Gideon Zamir; Norman L Letvin
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

Review 10.  Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.

Authors:  Philip V Nguyen; Jessica K Kafka; Victor H Ferreira; Kristy Roth; Charu Kaushic
Journal:  Cell Mol Immunol       Date:  2014-06-30       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.